Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy: A Growth Curve Model.

Rashid, Mamunur; Heikkonen, Jorma; Singh, Arun D; Kivelä, Tero T

Rashid, Mamunur; Heikkonen, Jorma; Singh, Arun D; Kivelä, Tero T.

Affiliation

Rashid M; Ocular Oncology Service, Department of Ophthalmology University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Electronic address: ext-mohammed.mamunur-rashid@hus.fi.
Heikkonen J; Department of Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Singh AD; Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
Kivelä TT; Ocular Oncology Service, Department of Ophthalmology University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Ophthalmology ; 125(5): 747-754, 2018 05.

Article in En | MEDLINE | ID: mdl-29499831

Subject(s)

Brachytherapy/methods; Choroid Neoplasms/radiotherapy; Iodine Radioisotopes/therapeutic use; Melanoma/radiotherapy; Ruthenium Radioisotopes/therapeutic use; Adolescent; Adult; Aged; Aged, 80 and over; Choroid Neoplasms/diagnostic imaging; Choroid Neoplasms/pathology; Female; Humans; Linear Models; Male; Melanoma/diagnostic imaging; Melanoma/pathology; Middle Aged; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Ultrasonography

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Brachytherapy / Ruthenium Radioisotopes / Choroid Neoplasms / Iodine Radioisotopes / Melanoma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ophthalmology Year: 2018 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google